Quince Therapeutics, Inc. (QNCX NASDAQ) stock market data APIs
$1.5992
0(0%)
as of September 15, 2025
Try our APIs with
free plan!
Quince Therapeutics, Inc. Financial Data Overview
Price chart is built with
Anychart
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Prev. Close
1.5992
Open
1.5992
High
1.617
Low
1.5807
52 wk Range
0.69-2.45
Market Cap
85 942 K
Shares Outstanding
53 714 K
EPS
-0.34
Beta
0.997
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Quince Therapeutics, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Quince Therapeutics, Inc. data using free add-ons & libraries
Get Quince Therapeutics, Inc. Fundamental Data
Quince Therapeutics, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -38 815 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-11
- EPS/Forecast: -0.26
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Quince Therapeutics, Inc. News
New
Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
Marks major milestone with completion of enrollment in pivotal Phase 3 NEAT clinical trial evaluating lead asset, eDSP, for the treatment of A-T; topline results expected in first quarter of 2026 Clo...
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP
Provides access to broad-reaching nationwide network of specialty pharmacy and ambulatory infusion suites across the U.S. SOUTH SAN FRANCISCO, Calif. & BANNOCKBURN, Ill., August 07, 2025--(BUSINESS W...
Quince Therapeutics registers up to 17.3M shares for resale by investors
* Quince Therapeutics (NASDAQ:QNCX [https://seekingalpha.com/symbol/QNCX]) has registered up to 17.34M shares of common stock for resale by selling stockholders. * The registration includes 6.67M ...
Quince Therapeutics announces pricing of up to $22M private placement; shares up 22%
* Quince Therapeutics (NASDAQ:QNCX [https://seekingalpha.com/symbol/QNCX]) announces a private placement expected to generate $11.5M in upfront proceeds. * The deal includes common stock (or pre-f...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
